Oral Liken Planus
Özet
Oral Liken Planus (OLP), mukoza tutulumu ile seyreden inflamatuar bir hastalıktır. Klinikte, retiküler, erozif, atrofik ve plak benzeri gibi çeşitli lezyonlar görülmektedir. Tanı, hastanın öyküsü, fizik muayene ve histolojik bulgularla konulmaktadır. Ayırıcı tanıda diğer hastalıkların dışlanması önemlidir. Tedavi, semptom kontrolü ve malign dönüşüm riskinin azaltılmasına odaklanmaktadır. Kortikosteroidler, kalsinörin inhibitörleri, immünsüpresanlar ve biyolojik ajanlar gibi çeşitli tedaviler kullanılmaktadır. Tedavi seçimi, semptomların şiddeti, hastanın genel durumu ve yan etki profiline göre yapılmaktadır. Tedavi sürecinde hastaların düzenli takibi ve semptomların izlenmesi önemlidir. OLP'nin tedavisi, multidisipliner bir yaklaşım gerektirir ve hastanın özelliklerine göre bireyselleştirilmelidir.
Oral Lichen Planus (OLP) is an inflammatory disease characterized by mucosal involvement. Clinical presentation includes various lesions such as reticular, erosive, atrophic, and plaque-like. Diagnosis is based on patient history, physical examination, and histological findings, with exclusion of other diseases being crucial. Treatment aims at symptom control and reducing the risk of malignant transformation. Various therapies like corticosteroids, calcineurin inhibitors, immunosuppressants, and biological agents are utilized. Treatment selection depends on the severity of symptoms, patient's overall condition, and potential side effects. Regular monitoring of patients and symptom management are essential during the treatment process. Managing OLP requires a multidisciplinary approach and should be personalized according to individual patient characteristics.
Referanslar
Olson MA, Rogers III RS, Bruce AJ. Oral lichen planus. Clinics in dermatology. 2016;34(4):495-504.
Bouquot JE, Gorlin RJ. Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years. Oral Surgery, Oral Medicine, Oral Pathology. 1986;61(4):373-381.
Carrozzo M, Dametto E, Fasano ME, et al. Tumor necrosis factor-α and interferon-γ polymorphisms contribute to susceptibility to oral lichen planus. Journal of Investigative Dermatology. 2004;122(1):87-94.
Scully C, El‐Kom M. Lichen planus: review and update on pathogenesis. Journal of Oral Pathology & Medicine. 1985;14(6):431-458.
Parashar P. Oral lichen planus. Otolaryngologic clinics of North America. 2011;44(1):89-107.
Mollaoglu N. Oral lichen planus: a review. British Journal of oral and maxillofacial surgery. 2000;38(4):370-377.
Sugerman PB, Savage NW, Zhou X, et al. Oral lichen planus. Clinics in dermatology. 2000;18(5):533-539.
Regezi JA, Sciubba J, Jordan RC. Oral pathology: clinical pathologic correlations. St.Louis: Elsevier Health Sciences; 2016.
Andreasen J. Oral lichen planus: I. A clinical evaluation of 115 cases. Oral Surgery, Oral Medicine, Oral Pathology. 1968;25(1):31-42.
Farhi D, Dupin N. Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clinics in dermatology. 2010;28(1):100-108.
Van der Waal I. Oral lichen planus and oral lichenoid lesions; a critical appraisal with emphasis on the diagnostic aspects. Medicina oral, patologia oral y cirugia bucal. 2009;14(7):E310-E4.
Bricker SL, editor Oral lichen planus: a review. Seminars in Dermatology; 1994.
Epstein JB, Wan LS, Gorsky M, et al. Oral lichen planus: progress in understanding its malignant potential and the implications for clinical management. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2003;96(1):32-37.
Ismail SB, Kumar SK, Zain RB. Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. Journal of oral science. 2007;49(2):89-106.
Marder MZ, Deesen KC. Transformation of oral lichen planus to squamous cell carcinoma: a literature review and report of case. The Journal of the American Dental Association. 1982;105(1):55-60.
Van der Meij E, Van der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. Journal of oral pathology & medicine. 2003;32(9):507-512.
Scully C, Beyli M, Ferreiro MC, et al. Update on oral lichen planus: etiopathogenesis and management. Critical Reviews in Oral Biology & Medicine. 1998;9(1):86-122.
Burket LW. Oral medicine: diagnosis and treatment. Philadelphia: Lippincott; 1952.
Radfar L, Wild RC, Suresh L. A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2008;105(2):187-193.
Zegarelli D. The treatment of oral lichen planus. Annals of dentistry. 1993;52(2):3-8.
Eisen D. The therapy of oral lichen planus. Critical Reviews in Oral Biology & Medicine. 1993;4(2):141-158.
Carbone M, Goss E, Carrozzo M, et al. Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long‐term follow‐up. Journal of oral pathology & medicine. 2003;32(6):323-329.
Thongprasom K, Dhanuthai K. Steriods in the treatment of lichen planus: a review. Journal of oral science. 2008;50(4):377-385.
Alsubhi A, Salem N, Mohab M, A, et al. Intralesional corticosteroid injections for the treatment of oral lichen planus: A systematic review. Journal of Dermatology and Dermatologic Surgery. 2020;24(2):74-80.
Al-Hashimi I, Schifter M, Lockhart PB, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2007;103:S25. e1-S. e12.
Yoke PC, Tin GB, Kim M-J, et al. A randomized controlled trial to compare steroid with cyclosporine for the topical treatment of oral lichen planus. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2006;102(1):47-55.
Al Johani KA, Hegarty AM, Porter SR, et al. Calcineurin inhibitors in oral medicine. Journal of the American Academy of Dermatology. 2009;61(5):829-840.
Rozycki TW, Rogers III RS, Pittelkow MR, et al. Topical tacrolimus in the treatment of symptomatic oral lichen planus: a series of 13 patients. Journal of the American Academy of Dermatology. 2002;46(1):27-34.
Petruzzi M, Lucchese A, Lajolo C, et al. Topical retinoids in oral lichen planus treatment: an overview. Dermatology. 2013;226(1):61-67.
Zhang J, Zhou G, Du GF, et al. Biologics, an alternative therapeutic approach for oral lichen planus. Journal of oral pathology & medicine. 2011;40(7):521-524.
Chao TJ. Adalimumab in the management of cutaneous and oral lichen planus. Cutis. 2009;84(6):325-328.
Yarom N. Etanercept for the management of oral lichen planus. American journal of clinical dermatology. 2007;8:121-.
Rebora A, Parodi A, Murialdo G. Basiliximab is effective for erosive lichen planus. Archives of dermatology. 2002;138(8):1100-1101.
Parmentier L, Bron B-A, Prins C, et al. Mucocutaneous lichen planus with esophageal involvement: successful treatment with an anti-CD20 monoclonal antibody. Archives of dermatology. 2008;144(11):1427-1430.
Referanslar
Olson MA, Rogers III RS, Bruce AJ. Oral lichen planus. Clinics in dermatology. 2016;34(4):495-504.
Bouquot JE, Gorlin RJ. Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years. Oral Surgery, Oral Medicine, Oral Pathology. 1986;61(4):373-381.
Carrozzo M, Dametto E, Fasano ME, et al. Tumor necrosis factor-α and interferon-γ polymorphisms contribute to susceptibility to oral lichen planus. Journal of Investigative Dermatology. 2004;122(1):87-94.
Scully C, El‐Kom M. Lichen planus: review and update on pathogenesis. Journal of Oral Pathology & Medicine. 1985;14(6):431-458.
Parashar P. Oral lichen planus. Otolaryngologic clinics of North America. 2011;44(1):89-107.
Mollaoglu N. Oral lichen planus: a review. British Journal of oral and maxillofacial surgery. 2000;38(4):370-377.
Sugerman PB, Savage NW, Zhou X, et al. Oral lichen planus. Clinics in dermatology. 2000;18(5):533-539.
Regezi JA, Sciubba J, Jordan RC. Oral pathology: clinical pathologic correlations. St.Louis: Elsevier Health Sciences; 2016.
Andreasen J. Oral lichen planus: I. A clinical evaluation of 115 cases. Oral Surgery, Oral Medicine, Oral Pathology. 1968;25(1):31-42.
Farhi D, Dupin N. Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clinics in dermatology. 2010;28(1):100-108.
Van der Waal I. Oral lichen planus and oral lichenoid lesions; a critical appraisal with emphasis on the diagnostic aspects. Medicina oral, patologia oral y cirugia bucal. 2009;14(7):E310-E4.
Bricker SL, editor Oral lichen planus: a review. Seminars in Dermatology; 1994.
Epstein JB, Wan LS, Gorsky M, et al. Oral lichen planus: progress in understanding its malignant potential and the implications for clinical management. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2003;96(1):32-37.
Ismail SB, Kumar SK, Zain RB. Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. Journal of oral science. 2007;49(2):89-106.
Marder MZ, Deesen KC. Transformation of oral lichen planus to squamous cell carcinoma: a literature review and report of case. The Journal of the American Dental Association. 1982;105(1):55-60.
Van der Meij E, Van der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. Journal of oral pathology & medicine. 2003;32(9):507-512.
Scully C, Beyli M, Ferreiro MC, et al. Update on oral lichen planus: etiopathogenesis and management. Critical Reviews in Oral Biology & Medicine. 1998;9(1):86-122.
Burket LW. Oral medicine: diagnosis and treatment. Philadelphia: Lippincott; 1952.
Radfar L, Wild RC, Suresh L. A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2008;105(2):187-193.
Zegarelli D. The treatment of oral lichen planus. Annals of dentistry. 1993;52(2):3-8.
Eisen D. The therapy of oral lichen planus. Critical Reviews in Oral Biology & Medicine. 1993;4(2):141-158.
Carbone M, Goss E, Carrozzo M, et al. Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long‐term follow‐up. Journal of oral pathology & medicine. 2003;32(6):323-329.
Thongprasom K, Dhanuthai K. Steriods in the treatment of lichen planus: a review. Journal of oral science. 2008;50(4):377-385.
Alsubhi A, Salem N, Mohab M, A, et al. Intralesional corticosteroid injections for the treatment of oral lichen planus: A systematic review. Journal of Dermatology and Dermatologic Surgery. 2020;24(2):74-80.
Al-Hashimi I, Schifter M, Lockhart PB, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2007;103:S25. e1-S. e12.
Yoke PC, Tin GB, Kim M-J, et al. A randomized controlled trial to compare steroid with cyclosporine for the topical treatment of oral lichen planus. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2006;102(1):47-55.
Al Johani KA, Hegarty AM, Porter SR, et al. Calcineurin inhibitors in oral medicine. Journal of the American Academy of Dermatology. 2009;61(5):829-840.
Rozycki TW, Rogers III RS, Pittelkow MR, et al. Topical tacrolimus in the treatment of symptomatic oral lichen planus: a series of 13 patients. Journal of the American Academy of Dermatology. 2002;46(1):27-34.
Petruzzi M, Lucchese A, Lajolo C, et al. Topical retinoids in oral lichen planus treatment: an overview. Dermatology. 2013;226(1):61-67.
Zhang J, Zhou G, Du GF, et al. Biologics, an alternative therapeutic approach for oral lichen planus. Journal of oral pathology & medicine. 2011;40(7):521-524.
Chao TJ. Adalimumab in the management of cutaneous and oral lichen planus. Cutis. 2009;84(6):325-328.
Yarom N. Etanercept for the management of oral lichen planus. American journal of clinical dermatology. 2007;8:121-.
Rebora A, Parodi A, Murialdo G. Basiliximab is effective for erosive lichen planus. Archives of dermatology. 2002;138(8):1100-1101.
Parmentier L, Bron B-A, Prins C, et al. Mucocutaneous lichen planus with esophageal involvement: successful treatment with an anti-CD20 monoclonal antibody. Archives of dermatology. 2008;144(11):1427-1430.
